About Cyrus Biotechnology
Cyrus Biotechnology is a company based in Seattle (United States) founded in 2014.. Cyrus Biotechnology has raised $31.99 million across 11 funding rounds from investors including HHS, Orbimed and Trinity Ventures. The company has 23 employees as of December 31, 2022. Cyrus Biotechnology has completed 1 acquisition, including Orthogonal Biologics. Cyrus Biotechnology offers products and services including IdeS, IL-22 Variant, and sACE2.v2-Fc. Cyrus Biotechnology operates in a competitive market with competitors including Vividion Therapeutics, Seer, Biognosys, ProteinSimple and NiKang Therapeutics, among others.
- Headquarter Seattle, United States
- Employees 23 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cyrus Biotechnology Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$31.99 M (USD)
in 11 rounds
-
Latest Funding Round
$300 K (USD), Grant
Dec 20, 2024
-
Investors
HHS
& 10 more
-
Employee Count
23
as on Dec 31, 2022
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cyrus Biotechnology
Cyrus Biotechnology offers a comprehensive portfolio of products and services, including IdeS, IL-22 Variant, and sACE2.v2-Fc. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Protein for IgG depletion in autoimmune diseases.
Fusion protein for gastrointestinal and metabolic conditions.
Candidate for COVID-19 prophylaxis in immunocompromised individuals.
Unlock access to complete
Unlock access to complete
Funding Insights of Cyrus Biotechnology
Cyrus Biotechnology has successfully raised a total of $31.99M across 11 strategic funding rounds. The most recent funding activity was a Grant round of $300 thousand completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Grant — $300,000
-
First Round
First Round
(06 May 2015)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2024 | Amount | Grant - Cyrus Biotechnology | Valuation |
investors |
|
| Sep, 2024 | Amount | Grant - Cyrus Biotechnology | Valuation |
investors |
|
| Feb, 2024 | Amount | Series B - Cyrus Biotechnology | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cyrus Biotechnology
Cyrus Biotechnology has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Orbimed and Trinity Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in early-stage technology and real estate companies.
|
Founded Year | Domain | Location | |
|
Agent Capital is focused on healthcare venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cyrus Biotechnology
Cyrus Biotechnology has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Orthogonal Biologics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Protein drug manufacturing and research services are provided.
|
2020 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Cyrus Biotechnology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cyrus Biotechnology Comparisons
Competitors of Cyrus Biotechnology
Cyrus Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Vividion Therapeutics, Seer, Biognosys, ProteinSimple and NiKang Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
Proteomics platform developed for early cancer and neurological disease detection.
|
|
| domain | founded_year | HQ Location |
Proteomics services are delivered via discovery and targeted platforms.
|
|
| domain | founded_year | HQ Location |
Provider tools to help researchers with protein analysis
|
|
| domain | founded_year | HQ Location |
Small molecule oncology therapeutics are developed for cancer treatment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cyrus Biotechnology
Frequently Asked Questions about Cyrus Biotechnology
When was Cyrus Biotechnology founded?
Cyrus Biotechnology was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Where is Cyrus Biotechnology located?
Cyrus Biotechnology is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Is Cyrus Biotechnology a funded company?
Cyrus Biotechnology is a funded company, having raised a total of $31.99M across 11 funding rounds to date. The company's 1st funding round was a Series B of $2.69M, raised on May 06, 2015.
How many employees does Cyrus Biotechnology have?
As of Dec 31, 2022, the latest employee count at Cyrus Biotechnology is 23.
What does Cyrus Biotechnology do?
Cyrus Biotechnology was founded in 2014 in Seattle, United States, within the biotechnology sector. Cloud-based software for protein modeling in drug discovery is provided. The primary product, Cyrus Bench, is offered as a modified version of the open-source Rosetta molecular modeling tool. This is bundled with essential bio-molecular computation resources, including BLAST, and features a custom user interface to support full utilization.
Who are the top competitors of Cyrus Biotechnology?
Cyrus Biotechnology's top competitors include Vividion Therapeutics, Biognosys and NiKang Therapeutics.
What products or services does Cyrus Biotechnology offer?
Cyrus Biotechnology offers IdeS, IL-22 Variant, and sACE2.v2-Fc.
How many acquisitions has Cyrus Biotechnology made?
Cyrus Biotechnology has made 1 acquisition, including Orthogonal Biologics.
Who are Cyrus Biotechnology's investors?
Cyrus Biotechnology has 11 investors. Key investors include HHS, Orbimed, Trinity Ventures, Agent Capital, and Alumni Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.